Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Carter Bankshares, Inc.NASDAQ: CARE
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $130.16M rose 110.2% year over year, ahead of the +31.5% change in trailing-twelve-month revenue. Sequentially, it rose 101.7% from the prior quarter. Over 3 fiscal years it compounded at +12.4% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 1 analysts of $258.3M (+1.4%) for the fiscal year ending Dec 2026, a slowdown from the +6.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $130.16M+101.7% QoQ
- Last fiscal yearDec 2025
- $254.63M+6.2% YoY
- LTMMar 2026
- $319.93M+31.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +110.2% | -9.3% | -119.6 pp |
| 1 year | +6.2% | +1.4% | -4.8 pp |
| 3-year CAGR | +12.4% | -5.3% | -17.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 254.63M USD
- Year-over-year change
- +6.2%
- 4-year CAGR
- +13.0%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 254.63M | +6.2% |
| FY2024 | 2024-12-31 | 239.67M | +13.1% |
| FY2023 | 2023-12-31 | 211.82M | +18.2% |
| FY2022 | 2022-12-31 | 179.15M | +14.6% |
| FY2021 | 2021-12-31 | 156.38M | — |
Revenue vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 revenue of $319.93M is the 2nd highest of the 11 companies compared; the peer median is $197.24M.
- Its year-over-year change of +31.5% is the highest of 11, against a peer median of +6.3%.
- Over three fiscal years its annual growth of +12.4% compares with a peer median of +14.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $616.78M | -10.6% | +12.3% | |
| LTM Mar 2026 | $319.93M | +31.5% | +12.4% | |
| LTM Mar 2026 | $248.24M | +7.2% | +30.0% | |
| LTM Mar 2026 | $242.77M | +7.4% | +14.7% | |
| LTM Mar 2026 | $211.83M | +7.8% | +19.7% | |
| LTM Mar 2026 | $205.66M | -4.4% | +20.7% | |
| LTM Mar 2026 | $188.81M | +10.9% | +14.7% | |
| LTM Mar 2026 | $175.19M | -0.4% | +9.2% | |
| LTM Mar 2026 | $143.92M | -11.1% | -3.9% | |
| LTM Mar 2026 | $122.65M | +8.5% | +13.5% | |
| LTM Mar 2026 | $86.08M | +5.5% | +10.9% | |
| Peer median (excluding CARE) | $197.24M | +6.3% | +14.1% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 156.38M | 179.15M | 211.82M | 239.67M | 254.63M |
| Cost of Revenue | 24.8M | 23.18M | 80.51M | 102.23M | 97.57M |
| Gross Profit | 131.58M | 155.97M | 131.31M | 137.45M | 157.06M |
| Gross Margin | 84.1% | 87.1% | 62.0% | 57.3% | 61.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.27M | 55.85M | 62.45M | 66.65M | 75.36M |
| Operating Expenses | 95.89M | 94.25M | 102.59M | 106.58M | 117.05M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| EBITDA | 41.93M | 67.78M | 34.97M | 37.92M | 47.86M |
| EBITDA Margin | 26.8% | 37.8% | 16.5% | 15.8% | 18.8% |
| Operating Income | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Operating Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Interest Income | 133.78M | 160.03M | 194.96M | 220.72M | 232.22M |
| Interest Expense | 22.71M | 20.25M | 74.11M | 107.27M | 101.4M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Pre-Tax Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Income Tax Expense | 4.11M | 11.6M | 5.34M | 6.35M | 8.64M |
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Net Margin | 20.2% | 28.0% | 11.0% | 10.2% | 12.3% |
| EPS (Basic) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| EPS (Diluted) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| Weighted Avg Shares | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
| Weighted Avg Shares (Diluted) | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.